Rational design of antitumor prostaglandins with high biological stability. (Record no. 9650975)

MARC details
000 -LEADER
fixed length control field 01483 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513150149.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199808s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0022-2623
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1021/jm9801657
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Suzuki, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19980817
245 00 - TITLE STATEMENT
Title Rational design of antitumor prostaglandins with high biological stability.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of medicinal chemistry
Date of publication, distribution, etc. Jul 1998
300 ## - PHYSICAL DESCRIPTION
Extent 3084-90 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Division
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclin-Dependent Kinase Inhibitor p21
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclins
General subdivision biosynthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Design
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Screening Assays, Antitumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Stability
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element G1 Phase
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostaglandins
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rats
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stereoisomerism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Structure-Activity Relationship
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kiho, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tomokiyo, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Furuta, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fukushima, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Takeuchi, Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nakanishi, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Noyori, R
773 0# - HOST ITEM ENTRY
Title Journal of medicinal chemistry
Related parts vol. 41
-- no. 16
-- p. 3084-90
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1021/jm9801657">https://doi.org/10.1021/jm9801657</a>
Public note Available from publisher's website

No items available.